neuraxial morphinemorphinepreeclampsiaparacetamolUZ Leuventhrombocytopeniadexamethasone
…ffects.27–29 Therefore, PROSPECT recommends, as alternatives to neuraxial morphine, single shot or continuous local anesthetic wound infiltration …
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 24 of 2459warfarinApixabanRivaroxabanCoronary artery diseaseDabigatran
… LV thrombus management, with comparable efficacy and safety to warfarin. Furthermore, our findings suggest more favourable clinical out…
ixekizumabpsoriatic arthritisPsAaxSpAaxial spondyloarthritis
…n rate and improvement in all disease activity outcomes suggest ixekizumab as a viable option for patients with multiple b/tsDMARD failure…
Inflammatory bowel diseaseChatGPT-4oDeepSeek-R1IBDDeepSeekDeepSeek-R1DomainChatGPT-4oDeepSeek-R1PChatGPT
…Background Inflammatory bowel disease (IBD) patients face fertility-related concerns, yet reliable in…
Bempedoic acidheterozygous familial hypercholesterolaemiaBADiabetesezetimibehypercholesterolaemiaheterozygous familial hypercholesterolemiaEZE-FDC
…. cData missing for 14 patients.BA, bempedoic acid; BA+EZE-FDC. Bempedoic acid/ezetimibe fixed-dose combination; HeFH, heterozygous familial h…
Heart Failurepalliative care
…ology Congresses2899506618 (0.62%)15 (0.30%)17 (0.59%)15 (0.30%)Heart Failure Society for America Annual Scientific MeetingsNA5315NA24 (0.45%…
Systemic sclerosis (SSc)DivozilimabDIVSScPBOmycophenolate mofetilMMFNCT05726630
…Introduction Systemic sclerosis (SSc) is a systemic autoimmune disease with important role of B-cells…
pancreatic ductal adenocarcinomaprostate cancerendometrial cancerbreast cancerlung cancerlymph node metastasisadjuvant therapylung cancerPublic
… missing variables. Bradley et al developed a BN on survival in pancreatic ductal adenocarcinoma and evaluated the impact of at least two missing variables on t…
Migraine headachesmigrainecalcium channel blockersCochrane Centralbeta-blockers
…Objectives Migraine headaches are common and potentially disabling disorders, with several in…
95.6%
BK virus associated nephropathycalcineurin inhibitorsGlomerulonephritismTOR inhibitorsBK virus nephropathyAmerican Society of TransplantationEuropean Medicines AgencyAmerican Society of Transplant Surgeonscalcineurinend stage kidney disease+3 more
… recurrence of the initial nephropathy, 175 patients (4.4%) had BK virus associated nephropathy, 3658 patients (92.8%) were treated with calcineurin inhibitors…
tuberculosis
…and regimens entering human trials. For decades, drug resistant tuberculosis required at least 18 months of second line and third line combi…
pembrolizumabnivolumabipilimumabmyasthenia gravismyositis-myocarditis-myasthenia gravis
…ortal outcome) as a suspected ADR of different ICIs (nivolumab, pembrolizumab and nivolumab+ipilimumab) within 2 months in the regional Pharm…